Although outcomes with aripiprazole and aripiprazole+valproate were superior to placebo in the unadjusted analysis, the results did not reach statistical significance in the sensitivity analyses.
← all excerpts
Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
1
—
—